Evidence map›Paper›PMID 22392862›Full record

ReviewCirculation2012

Acute coronary events.

Armin Arbab-Zadeh, Masataka Nakano, Renu Virmani, Valentin Fuster

Abstract readReview
In one paragraph

Review in Circulation, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 121 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
121citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

121 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Prospective Assessment of Biomarkers of Hypercoagulability for the Identification of Patients With Severe Coronary Artery Disease. The ROADMAP-CAD Study.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Trial
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Observational
  15. Review
  16. Review
  17. Review
  18. Residual risks and evolving atherosclerotic plaques.Molecular and cellular biochemistry · 2023
    Review
  19. Article
  20. Review

61 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Armin Arbab-ZadehJohns Hopkins Hospital, Baltimore, MD 21287-0409, USA. arminzadeh@jhu.edu
Masataka Nakano
Renu Virmani
Valentin Fuster

Funding

Quantification and Characterization of Coronary Atherosclerotic Plaque by CTK23HL098368 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI ZADEH, ARMIN A. · 2011 to 2015
$699k
NHLBI NIH HHS 1K23HL098368NHLBI NIH HHS K23 HL098368
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Acute Coronary SyndromeAngina PectorisCoronary Artery DiseaseCoronary ThrombosisHumansMorbidityMyocardial InfarctionRisk FactorsUnited States

Identifiers

PMID22392862
PMCPMC3322378

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.